These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26289790)

  • 1. Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas.
    Mohindra N; Agulnik M
    Expert Opin Investig Drugs; 2015; 24(11):1409-18. PubMed ID: 26289790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pazopanib in the treatment of soft tissue sarcoma.
    Schöffski P
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):711-23. PubMed ID: 22716487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pazopanib a tyrosine kinase inhibitor with strong anti-angiogenetic activity: a new treatment for metastatic soft tissue sarcoma.
    Ranieri G; Mammì M; Donato Di Paola E; Russo E; Gallelli L; Citraro R; Gadaleta CD; Marech I; Ammendola M; De Sarro G
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):322-9. PubMed ID: 24041629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic soft tissue sarcoma: current treatment landscape and future perspectives.
    Skafida E; Kokkali S; Nikolaou M; Digklia A
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):537-543. PubMed ID: 28425820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pazopanib, a new therapy for metastatic soft tissue sarcoma.
    Verweij J; Sleijfer S
    Expert Opin Pharmacother; 2013 May; 14(7):929-35. PubMed ID: 23488774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial end points for assessing efficacy of novel therapies for soft-tissue sarcomas.
    Chmielowski B; Federman N; Tap WD
    Expert Rev Anticancer Ther; 2012 Sep; 12(9):1217-28. PubMed ID: 23098121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
    Kopp HG; Patel S; Brücher B; Hartmann JT
    Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in histology specific treatments in soft tissue sarcoma.
    Radaelli S; Merlini A; Khan M; Gronchi A
    Expert Rev Anticancer Ther; 2024 Sep; 24(9):845-868. PubMed ID: 39099398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How we use pazopanib in treating soft-tissue sarcoma: experience at our multidisciplinary sarcoma centers.
    Van Tine BA; Trent JC
    Curr Med Res Opin; 2019 Apr; 35(4):623-629. PubMed ID: 30652922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma.
    Martin-Liberal J; Pérez E; García Del Muro X
    Expert Opin Investig Drugs; 2019 Jan; 28(1):39-50. PubMed ID: 30513001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib.
    Wilding CP; Elms ML; Judson I; Tan AC; Jones RL; Huang PH
    Expert Rev Anticancer Ther; 2019 Nov; 19(11):971-991. PubMed ID: 31665941
    [No Abstract]   [Full Text] [Related]  

  • 12. Pazopanib: a promising new agent in the treatment of soft tissue sarcomas.
    Kasper B; Hohenberger P
    Future Oncol; 2011 Dec; 7(12):1373-83. PubMed ID: 22112314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 1 clinical trials for sarcomas: the cutting edge.
    Subbiah V; Kurzrock R
    Curr Opin Oncol; 2011 Jul; 23(4):352-60. PubMed ID: 21519259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.
    Chamberlain FE; Wilding C; Jones RL; Huang P
    Expert Opin Investig Drugs; 2019 Jun; 28(6):505-511. PubMed ID: 31010343
    [No Abstract]   [Full Text] [Related]  

  • 15. Newer medical therapies for metastatic soft tissue sarcoma.
    Tiwari A; Gupta VG; Bakhshi S
    Expert Rev Anticancer Ther; 2017 Mar; 17(3):257-270. PubMed ID: 28103739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histology-Specific Chemotherapy in Soft-Tissue Sarcomas].
    Kobayashi E; Kawai A
    Gan To Kagaku Ryoho; 2017 Jun; 44(6):468-472. PubMed ID: 28698435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological profile and clinical results in advanced soft tissue sarcoma patients of pazopanib hydrochloride (Votrient(®))].
    Arai H; Fukasawa N; Ueta F
    Nihon Yakurigaku Zasshi; 2013 Jan; 141(1):37-42. PubMed ID: 23302947
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of biomarker testing in historically rare, high-unmet-need tumors: soft tissue sarcomas and thyroid cancers.
    Schroader B; Kong S; Anderson S; Williamson T; Sireci A; Shields K
    Expert Rev Anticancer Ther; 2019 Nov; 19(11):929-938. PubMed ID: 31622558
    [No Abstract]   [Full Text] [Related]  

  • 19. Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself.
    Yang QK; Chen T; Wang SQ; Zhang XJ; Yao ZX
    Angiogenesis; 2020 Aug; 23(3):279-298. PubMed ID: 32333216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs in sarcomas.
    Martin-Liberal J; Benson C; Judson I
    Expert Opin Pharmacother; 2014 Feb; 15(2):221-9. PubMed ID: 24266804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.